13.67
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$13.44
Offen:
$13.21
24-Stunden-Volumen:
1.27M
Relative Volume:
0.37
Marktkapitalisierung:
$2.05B
Einnahmen:
$5.75B
Nettoeinkommen (Verlust:
$77.00M
KGV:
27.90
EPS:
0.49
Netto-Cashflow:
$-675.00M
1W Leistung:
-9.11%
1M Leistung:
-18.11%
6M Leistung:
+19.06%
1J Leistung:
-31.28%
Chemours Company Stock (CC) Company Profile
Firmenname
Chemours Company
Sektor
Branche
Telefon
302 773 1000
Adresse
1007 MARKET STREET, WILMINGTON, DE
Vergleichen Sie CC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CC
Chemours Company
|
13.67 | 1.88B | 5.75B | 77.00M | -675.00M | 0.49 |
![]()
LIN
Linde plc Ordinary Share
|
459.44 | 212.80B | 33.25B | 6.89B | 5.07B | 14.07 |
![]()
SHW
Sherwin Williams Co
|
331.75 | 82.98B | 23.08B | 2.54B | 2.15B | 10.07 |
![]()
ECL
Ecolab Inc
|
270.10 | 77.17B | 15.72B | 2.16B | 1.57B | 7.4779 |
![]()
APD
Air Products Chemicals Inc
|
262.61 | 57.21B | 12.06B | 1.61B | -4.63B | 6.9564 |
![]()
DD
Dupont De Nemours Inc
|
76.39 | 30.86B | 12.61B | 109.00M | 1.32B | -0.4667 |
Chemours Company Stock (CC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-27 | Hochstufung | Mizuho | Neutral → Outperform |
2025-01-28 | Eingeleitet | Truist | Buy |
2024-07-09 | Hochstufung | UBS | Neutral → Buy |
2024-06-07 | Eingeleitet | Mizuho | Neutral |
2024-04-09 | Hochstufung | BMO Capital Markets | Underperform → Outperform |
2024-03-05 | Herabstufung | UBS | Buy → Neutral |
2024-02-29 | Herabstufung | BMO Capital Markets | Outperform → Underperform |
2023-12-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2023-06-22 | Herabstufung | BofA Securities | Buy → Neutral |
2023-01-24 | Hochstufung | UBS | Neutral → Buy |
2023-01-11 | Hochstufung | BofA Securities | Neutral → Buy |
2023-01-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2022-11-01 | Eingeleitet | Credit Suisse | Underperform |
2022-10-13 | Eingeleitet | Goldman | Neutral |
2022-10-05 | Herabstufung | Argus | Buy → Hold |
2022-06-14 | Herabstufung | BofA Securities | Buy → Neutral |
2021-06-10 | Eingeleitet | Wolfe Research | Outperform |
2021-06-09 | Hochstufung | Goldman | Neutral → Buy |
2021-05-20 | Eingeleitet | BofA Securities | Buy |
2021-05-06 | Hochstufung | Argus | Hold → Buy |
2021-01-08 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2020-12-04 | Herabstufung | Barclays | Overweight → Equal Weight |
2020-11-30 | Eingeleitet | Alembic Global Advisors | Overweight |
2020-03-23 | Herabstufung | Jefferies | Buy → Hold |
2020-02-14 | Hochstufung | CFRA | Buy → Strong Buy |
2019-11-06 | Hochstufung | CFRA | Hold → Buy |
2019-08-20 | Hochstufung | Susquehanna | Neutral → Positive |
2019-08-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2019-08-06 | Herabstufung | Argus | Buy → Hold |
2019-08-05 | Herabstufung | SunTrust | Buy → Hold |
2019-07-12 | Herabstufung | Citigroup | Buy → Neutral |
2019-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
2019-04-15 | Hochstufung | SunTrust | Hold → Buy |
2019-02-19 | Herabstufung | Susquehanna | Positive → Neutral |
2019-01-08 | Eingeleitet | HSBC Securities | Buy |
2019-01-04 | Hochstufung | Citigroup | Neutral → Buy |
2018-11-02 | Herabstufung | Citigroup | Buy → Neutral |
2018-07-18 | Eingeleitet | RBC Capital Mkts | Outperform |
2018-01-30 | Eingeleitet | Morgan Stanley | Equal-Weight |
2017-12-06 | Herabstufung | Goldman | Buy → Neutral |
2017-08-07 | Hochstufung | UBS | Sell → Neutral |
Alle ansehen
Chemours Company Aktie (CC) Neueste Nachrichten
Will The Chemours Company see short term momentumJuly 2025 Short Interest & Safe Capital Growth Stock Tips - newser.com
Regression analysis insights on The Chemours Company performanceTrade Entry Report & AI Forecasted Stock Moves - newser.com
A Short-Lived Win in a Never-Ending Fight Over Forever Chemicals - CityView NC
Why analysts remain bullish on The Chemours Company stockJuly 2025 Selloffs & Free Community Consensus Stock Picks - newser.com
Chemours' audacity: Fayetteville Works plant wants to expand PFAS | Opinion - The Fayetteville Observer
Is The Chemours Company (2CU) stock prepared for digital transitionAnalyst Downgrade & Low Drawdown Momentum Ideas - newser.com
Chemours (CC) Is Down 14.9% After Legal and Environmental Risks Intensify—Has the Bull Case Changed? - simplywall.st
How The Chemours Company stock benefits from global expansionJuly 2025 Setups & AI Forecast Swing Trade Picks - newser.com
The Chemours Company stock prediction for this weekMarket Sentiment Summary & AI Forecast for Swing Trade Picks - newser.com
What Fibonacci levels say about The Chemours Company reboundWeekly Earnings Recap & AI Driven Stock Price Forecasts - newser.com
How The Chemours Company stock reacts to bond yieldsPortfolio Update Summary & Smart Investment Allocation Insights - newser.com
How to use a screener to detect The Chemours Company breakoutsMarket Volume Report & Free High Accuracy Swing Entry Alerts - newser.com
Judge will not delay AG Jackson’s lawsuit against Chemours during appeal - Carolina Coast Online
What data driven models say about The Chemours Company’s futureForecast Cut & AI Enhanced Trade Execution Alerts - newser.com
Published on: 2025-10-13 04:12:05 - newser.com
Chemours enters 'final phase' of private well sampling program in Wilmington area - Wilmington Star-News
Chemours Co. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Chemours (CC): Assessing Valuation After Prolonged Share Price Pressure and Uncertainty - Yahoo Finance
Chemours (NYSE:CC) Shares Down 5.9%Here's What Happened - MarketBeat
Best data tools to analyze The Chemours Company stockPortfolio Performance Report & Reliable Intraday Trade Plans - newser.com
Published on: 2025-10-10 09:12:34 - newser.com
Trend analysis for The Chemours Company this weekQuarterly Trade Report & High Win Rate Trade Tips - newser.com
Will The Chemours Company stock recover after recent dropQuarterly Portfolio Report & Precise Entry and Exit Recommendations - newser.com
Weiss Ratings Reiterates "Sell (D)" Rating for Chemours (NYSE:CC) - MarketBeat
undefined - CSRwire
What analysts say about The Chemours Company 2CU stockEarnings Growth Projections & Minimal Capital Trading Tips - earlytimes.in
Using fundamentals and technicals on The Chemours CompanyJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com
Pigments Market Size Worth US$ 39.36 billion by 2031 | Chemours, - openPR.com
Chemours' Trusted Chemistry in Action: Improving Data Center Impact Through Liquid Cooling - ACCESS Newswire
Is Chemours Set for a Rebound After Recent Legal Settlement Shakes Up the Stock? - simplywall.st
Luminus Trims Its Hefty Chemours Position - AOL.com
UBS Maintains Chemours (CC) Buy Recommendation - Nasdaq
Chemours’ Approach to Responsible Manufacturing and Mining - CSRwire
UBS Raises Chemours (CC) Price Target to $21.00 and Reaffirms Bu - GuruFocus
UBS Adjusts Price Target on Chemours to $21 From $17, Maintains Buy Rating - MarketScreener
GAMMA Investing LLC Has $36,000 Position in The Chemours Company $CC - Defense World
Chemours’ Role In Shaping the Russell 1000 Index Performance - kalkinemedia.com
The Chemours Company’s volatility index tracking explainedChart Signals & AI Optimized Trading Strategy Guides - newser.com
Applying Elliott Wave Theory to The Chemours Company2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Can The Chemours Company (2CU) stock resist broad market declines2025 Short Interest & Verified Technical Signals - newser.com
3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending - MarketBeat
Head to Head Comparison: Chemours (NYSE:CC) vs. Lsb Industries (NYSE:LXU) - Defense World
Chemours (CC) Price Target Lifted by Mizuho Amid Higher Market Multiples - MSN
United States Titanium Market: Corrosion Resistance & Chemical - openPR.com
Chemours' Approach to Responsible Manufacturing and Mining - ReportAlert
Finanzdaten der Chemours Company-Aktie (CC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):